
Panic Attack Treatment Market to Reach USD 8.66 Billion, Globally by 2035 at 16.8% CAGR: Coherent Market Insights, Inc.
/EIN News/ -- Burlingame, CA, May 23, 2025 (GLOBE NEWSWIRE) -- According to projections, the global panic attack treatment market is expected to reach USD 2.92 billion in 2025 and expand to USD 8.66 billion by 2032, registering a compound annual growth rate (CAGR) of 16.8% during this period. Panic attack treatment encompasses both pharmacological and non-pharmacological approaches aimed at managing symptoms and reducing the frequency and intensity of panic attacks.
Request Sample Pages @ https://www.coherentmarketinsights.com/insight/request-sample/6460
Global Panic Attack Treatment Market Key Takeaways
According to Coherent Market Insights (CMI), the global panic attack treatment market size is forecast to expand nearly 3X, growing from USD 2.92 Bn in 2025 to USD 8.66 Bn by 2032.
Global demand for panic attack treatment will likely increase at a CAGR of 16.8% during the assessment period. This can be attributed to rising prevalence of panic disorder, a type of anxiety disorder.
By drug class, antidepressants segment is set to account for more than two-fifths of the global panic attack treatment market share in 2025.
North American panic attack treatment is estimated to be valued at around USD 1 Bn in 2025.
Europe is forecast to remain the second-leading market for panic attack treatments, accounting for nearly one-fourth of the global industry share.
As per CMI’s latest global panic attack treatment market analysis, Asia Pacific is anticipated to record fastest growth, owing to increasing prevalence of anxiety disorders, improving healthcare infrastructure, and growing mental health awareness.
Also Read: Anxiety Disorders and Depression Treatments Market Size, Share & Trends Analysis Report (2025-2032)
Rising Prevalence of Panic Attacks Spurring Market Growth
Coherent Market Insights’ latest global panic attack treatment market research highlights key factors driving industry growth. One such prominent growth driver is the increasing incidence of panic disorder and panic attacks.
The global prevalence of panic attacks has increased significantly. According to an article published by Cambridge University, the overall lifetime prevalence of panic attacks (PAs) across all countries combined is 13.2%. This surge is expected to create high demand for panic attack treatments.
Side Effects Limiting Global Panic Attack Treatment Market Growth
The future global panic attack treatment market outlook looks optimistic. However, side effects of panic attack treatments are expected to limit market growth to some extent.
Prolonged use of antidepressant and anti-anxiety drugs can cause side effects like fatigue, weight gain, sexual dysfunction, and memory issues. These adverse side effects often lead to treatment discontinuation, thereby limiting overall panic attack treatment market demand.
Usage of drugs like benzodiazepines may also lead to dependence or abuse. This can also negatively impact the global panic attack treatment market growth rate.
Get Customization on this Report for Specific Research Solutions: https://www.coherentmarketinsights.com/insight/request-customization/6460
Growing Mental Health Awareness and Destigmatization Creating Growth Avenues
People are gradually becoming aware of mental health issues and their devastating impact on physical, emotional, and economic aspects. As a result, more individuals are seeking professional help, thereby creating growth opportunities for panic attack drug manufacturers.
Governments and NGOs are actively launching initiatives and awareness campaigns to educate people about mental health. These efforts are helping reduce stigma associated with mental health issues, thereby fostering a conducive environment for the expansion of the panic attack treatment market.
Emerging Global Panic Attack Treatment Market Trends
Rising interest in personalized medicine is emerging as a key growth-shaping trend in the market. This trend is encouraging global panic attack treatment companies to develop more targeted drugs by using biomarkers and genetic profiling.
Another key trend shaping the market is the integration of pharmacological treatments with behavioral interventions, particularly Cognitive Behavioral Therapy (CBT). This combined approach is gaining traction for its effectiveness in combating panic attacks.
Advancements in medical research are paving way for the development of novel pharmacological therapies with high efficacy and better safety profiles. For instance, newer generation selective serotonin reuptake inhibitors (SSRIs) and targeted therapies are under investigation for managing panic disorder more effectively. Development and approval of such novel medications will likely boost market growth.
Expansion of telehealth platforms is improving accessibility to mental health services, especially in remote areas. This is expected to positively impact global panic attack treatment sales growth.
Leading companies are integrating advanced technologies like AI to develop predictive models as well as enhance diagnostics accuracy and personalize treatment plans. Such innovations are expected to create a conducive environment for the expansion of panic attack treatment industry.
Also Read: Mental Disorder Treatment Market Analysis: Size, Share, and Trend for 2025 to 2032
Analyst’s View
“The global panic attack treatment market is expected to grow rapidly, owing to increasing prevalence of anxiety disorders, growing mental health awareness, supportive government initiatives, and advancements in panic attack drugs,” said senior analyst Ghanshyam Shrivastava.
Current Events and Their Impact on the Panic Attack Treatment Market
Event | Description and Impact |
Rising Prevalence of Anxiety Disorders |
|
Destigmatization of Mental Health Issues |
|
Advancements in Telemedicine |
|
Competitor Insights
Key companies listed in global panic attack treatment market report include:
- Hoffmann-La Roche Ltd.
- AstraZeneca
- GlaxoSmithKline plc.
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Bausch Health Companies Inc.
- Johnson & Johnson Services, Inc.
- Lundbeck A/S
Key Developments
In January 2025, the U.S. FDA approved Johnson & Johnson’s supplemental New Drug Application for SPRAVATO. This approval designates SPRAVATO as the first and only monotherapy for adults with treatment-resistant depression (TRD).
In December 2024, Mind Medicine Inc. initiated dosing in its Phase 3 Voyage study, with the first patient receiving MM120 ODT for the treatment of generalized anxiety disorder (GAD).
Buy this Premium Panic Attack Treatment Research Report | Fast Delivery Available - [165+ Pages] @ https://www.coherentmarketinsights.com/insight/buy-now/6460
Global Panic Attack Treatment Market Detailed Segmentation:
By Drug Class
- Antidepressants
- Anti-anxiety Drugs
- CGRP Antagonists
- Others
By Route of Administration
- Oral
- Intravenous
- Intramuscular
- Sublingual
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Also Read: Bipolar Disorder Mood Stabilizers Market Size, Share & Trends Analysis (2025-2032)
Our Trusted Partners:
Worldwide Market Reports, Coherent MI, Stratagem Market Insights
Get Recent News:
https://www.coherentmarketinsights.com/news
About Us:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
For Latest Update Follow Us:
LinkedIn | Facebook | Twitter


Distribution channels: Banking, Finance & Investment Industry, Business & Economy, Science ...
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release